Le Lézard
Classified in: Health, Covid-19 virus
Subject: AVO

Physicians Ask: Are School 'Physicals' Adequate after COVID Jab?


TUCSON, Ariz., July 15, 2021 /PRNewswire/ -- On June 23, the Advisory Committee on Immunization Practices (ACIP) had an emergency meeting because of reports of myocarditis (heart inflammation) after COVID-19 shots. There were about 600 cases reported at that time; the number is now more than 1,200. The Centers for Disease Control and Prevention (CDC) concluded that this effect is "extremely rare" and "usually mild." It will continue to monitor, but still recommends the jab for persons age 12 and over.

The Food and Drug Administration (FDA) has added warnings about the possibility of myocarditis and pericarditis to vaccine Fact Sheets.

Hundreds of colleges are nonetheless still mandating a COVID jab to return to campus. The Association of American Physicians and Surgeons (AAPS) urges colleges, parents, students, and physicians to consider the following:

AAPS recommends that students be made aware of these facts. They should ask for an official college policy regarding COVID mandates, the person or persons responsible for it, and any provisions for screening, treatment, or compensation of students or employees mandated to receive these products who experience myocarditis or pericarditis. This is especially critical for those planning to engage in competitive athletics.

The Association of American Physicians and Surgeons has represented physicians in all specialties since 1943. Its motto is omnia pro aegroto, everything for the patient.

SOURCE Association of American Physicians and Surgeons (AAPS)


These press releases may also interest you

at 10:30
Omni Quality Living ("Omni"), a portfolio business of The Hillcore Group, a leader in long-term care and senior living, is pleased to announce effective July 2nd, 2024, it has assumed the management of five high-quality long-term care homes located...

at 10:11
The Prime Minister, Justin Trudeau, today announced the reappointment of Dr. Mona Nemer as Canada's Chief Science Advisor for a term of three years, effective September 25, 2024. A distinguished medical researcher, Dr. Nemer has served as Canada's...

at 10:10
The "TechVision50: Top 50 Advanced and Emerging Technologies" report has been added to ResearchAndMarkets.com's offering. TechVision50 is a guide of the 50 greatest opportunities in Advanced Technologies and Materials at the mid-point of 2024. This...

at 10:10
The "Viral Vector Collaboration and Licensing Deals 2016-2024" report has been added to ResearchAndMarkets.com's offering. Viral Vector Collaboration and Licensing Deals provides a comprehensive understanding and unprecedented access to the viral...

at 10:05
The "The Worldwide Market for Clinical Laboratory Services, 9th Edition" report has been added to ResearchAndMarkets.com's offering. Stay ahead with insights into demographic trends, disease trends, new developments, company performance, mergers...

at 10:00
The "Drug Delivery Collaboration and Licensing Deals 2016-2024" report has been added to ResearchAndMarkets.com's offering. Drug Delivery Collaboration and Licensing Deals provides a comprehensive understanding and unprecedented access to the drug...



News published on and distributed by: